phage display info.
whearl at aol.com
Sun Jun 30 23:03:58 EST 1996
I have been following the recombinant antibody story closely, and aside
from a small but active group of enthusists, the technology does not seem
to be living up to expectations yet. Conventional antibodies - monoclonal
or polyclonal - still generate proteins which have the most desirable
characteristics for biniding to target. I would be interested in hearing
from others who have tried the method. Is it working well for you? Do
you get antibodies which are better than MABs?
More information about the Immuno